AngioDynamics Inc ANGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANGO is a good fit for your portfolio.
News
-
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
-
AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
-
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
-
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
-
AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System
-
AngioDynamics Gets FDA Clearance For Pulmonary Embolism Treatment
-
AngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & Co
-
AngioDynamics stock dives after sales miss, lowered full-year outlook
Trading Information
- Previous Close Price
- $7.51
- Day Range
- $7.47–7.73
- 52-Week Range
- $5.26–9.43
- Bid/Ask
- $6.55 / $7.95
- Market Cap
- $306.42 Mil
- Volume/Avg
- 614,695 / 520,803
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.01
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 815
- Website
- https://www.angiodynamics.com
Comparables
Valuation
|
Metric
|
ANGO
|
SIBN
|
MMSI
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 27.25 |
Price/Book Value | 1.49 | 4.01 | 4.01 |
Price/Sales | 1.01 | 4.48 | 3.90 |
Price/Cash Flow | — | — | 21.91 |
Price/Earnings
ANGO
SIBN
MMSI
Financial Strength
|
Metric
|
ANGO
|
SIBN
|
MMSI
|
|---|---|---|---|
Quick Ratio | 1.38 | 8.63 | 4.22 |
Current Ratio | 2.12 | 9.76 | 6.03 |
Interest Coverage | — | −13.62 | 6.17 |
Quick Ratio
ANGO
SIBN
MMSI
Profitability
|
Metric
|
ANGO
|
SIBN
|
MMSI
|
|---|---|---|---|
Return on Assets (Normalized) | −3.55% | −7.83% | 9.17% |
Return on Equity (Normalized) | −4.72% | −10.72% | 15.14% |
Return on Invested Capital (Normalized) | −4.97% | −10.92% | 10.93% |
Return on Assets
ANGO
SIBN
MMSI
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Lyshkkdkr | Cpth | $156.8 Bil | |||
| Becton Dickinson & Co
BDX
| Ynkftwly | Fwqbrm | $68.6 Bil | |||
| Alcon Inc
ALC
| Jmbsyhww | Txcfts | $46.5 Bil | |||
| Coloplast A/S ADR
CLPBY
| Zxnwjxkgx | Ycqgg | $29.1 Bil | |||
| ResMed Inc
RMD
| Cfccggry | Ssdhvy | $28.9 Bil | |||
| West Pharmaceutical Services Inc
WST
| Xgzbytrd | Yhgj | $20.7 Bil | |||
| The Cooper Companies Inc
COO
| Mphfdnb | Vfbhsg | $18.6 Bil | |||
| Hologic Inc
HOLX
| Kcwbvqlj | Pmpwny | $18.4 Bil | |||
| Baxter International Inc
BAX
| Gjxmrpkx | Nxhrck | $18.1 Bil | |||
| Teleflex Inc
TFX
| Xqxdn | Nbys | $10.4 Bil |